Characteristics of enrolled patients at baseline according to outcome status^*.

<p>*Results may not add due to missing values.</p><p>**Only 7 patients were known to be HIV-positive because HIV testing is rarely performed.</p

Crude and adjusted marginal models assessing weight change over time according to outcome status.

<p>*Adjusted by age, gender, type of tuberculosis, scheme of treatment, HIV status, and sputum variation during follow-up.</p

Weight change over time during treatment follow-up according to outcome status (adjusted model*).

<p>* Predicted lines were adjusted for age, gender, type of tuberculosis, scheme of treatment, HIV status, and sputum variation during follow-up.</p

Weight change over time during follow-up according to outcome status.

<p>Weight change over time during follow-up according to outcome status.</p

List of primers used for the B&S MG-LAMP.

(DOCX)</p

Cost and TAT of B&S MG-LAMP assay and expert microscopy for 8 samples (One strip of tubes).

Cost and TAT of B&S MG-LAMP assay and expert microscopy for 8 samples (One strip of tubes).</p

Mixed infections results.

Comparison of results of mixed infections (Pf/Pv) performed by each methodology. (DOCX)</p

Comparison of the B&S MG-LAMP and field microscopy with expert microscopy.

(DOCX)</p

Individual test results for passive surveillance component.

(XLSX)</p

Study sites located in the region of Loreto, Peru.

The insert shows the location of the health facilities where samples were collected in Iquitos. Red circles showed the sites for the passive surveillance studies. The community of Padre Cocha (Blue) was a site for the passive and active surveillance study. Map created using open data from OpenStreetMap, under ODbL, under CC BY 2.0 (creativecommons.org/licenses/by/2.0/).</p